SOURCES SOUGHT
66 -- MICRO-IMAGING UPGRADE
- Notice Date
- 3/14/2011
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, Bldg 50 Room 422, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- FDA1085919
- Archive Date
- 4/13/2011
- Point of Contact
- Regina R. Williams, Phone: (870) 543-7012
- E-Mail Address
-
regina.williams@fda.hhs.gov
(regina.williams@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a SOURCES SOUGHT NOTICE to determine the availability and capability of potential small businesses (including HUBZone firms; certified 8(a), Small Disadvantaged, veteran and service-disabled veteran-owned small businesses, and women-owned small businesses. The U.S. Food and Drug Administration (FDA) is seeking capability statements from companies that are capable of providing a Micro-Imaging upgrade (gradients and probe) to interface to an existing Varian Nuclear Magnetic Resonance Spectrometer. The Micro-Imaging System upgrade will be used for the identification of physical changes and chemical changes of drug components in drug products capsules and tablets by the Center for Drug Evaluation and Research, Division of Product Quality Research. The system must meet the following requirements: •The system must interface with an existing Varian 400 MHz Nuclear Magnetic Resonance Spectrometer. •Must be capable of conducting non-invasive magnetic resonance imaging tablets and capsule. •Must be capable of conducting experiments with proprietary mr pulse sequences non-invasive magnetic resonance imaging of tablet and capsule. •Must be capable of utilizing high-field gradients non-invasive magnetic resonance imaging of tablets and capsule with the following specifications: 120A Microimaging 208 VAC, 12 three axes constant current gradient driver, conducts NMR and MRI applications, 120 A full range, Output 10 A steady state DC current of 1.25 sec max., peak output 120 A, 50 A at 10% or 25% duty cycle, and 10 A continuous. •Installation and training included. The associated North American Industry Classification System (NAICS) Code is 334516 - Analytical Laboratory Instrument Manufacturing, Small Business Size Standard is 500 employees. Interested offerors should submit their capability statement not exceeding fifteen (15) pages in length, excluding standard brochures. Potential contractors must indicate business size, proof of any set-aside certification and company's DUNS number and provide a contact name, the mailing address, phone number, email address of point of contact. Identification of the firm's GSA Schedule contract(s) by Schedule number and contract number and SINs that are applicable to this potential requirement are also requested. Capability statements must provide enough information to determine if the company can meet the requirement. At a minimum provide the following: All descriptive material necessary for the government to determine whether the product offered meets the technical requirements including: technical specifications, descriptive material, literature, brochures and other information corresponding to each item, which demonstrates the capabilities of the contractor to meet the requirement. Interested Contractors must respond with capability statements which are due in person, by postal mail, fax or email to the point of contact listed below on or before March 29, 2011 1:00 pm (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, Office of Acquisitions and Grants Services, Attn: Regina Williams, 3900 NCTR Road, HFT-320, Jefferson, AR 72079-9502. Reference solicitation number FDA1085919 Disclaimer and Important Notes. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA1085919/listing.html)
- Place of Performance
- Address: FDA/CDER, White Oak Campus, Bldg 62, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN02400238-W 20110316/110314234437-464f2c10412f85eb7322864c66b8d6b5 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |